Literature DB >> 31859033

A Retrospective Study to Identify Novel Factors Associated with Post-stroke Anxiety.

Jennifer E Sanner Beauchamp1, Tahani Casameni Montiel2, Chunyan Cai3, Sudha Tallavajhula3, Evelyn Hinojosa4, Munachi N Okpala5, Farhaan S Vahidy5, Sean I Savitz5, Anjail Z Sharrief5.   

Abstract

BACKGROUND AND
PURPOSE: Post-stroke anxiety (PSA) is common and disabling. PSA should be considered as an important outcome in stroke. However, there is a lack of understanding of factors that may be linked to PSA. The purpose of this study was to determine the frequency of PSA and sociodemographic and clinical factors associated with PSA in a cohort of racially and ethnically diverse stroke patients.
METHODS: We conducted a retrospective study of ischemic and hemorrhagic stroke patients seen in a stroke outpatient clinic from August 1, 2017 to June 30, 2018. Patients were eligible if a Generalized Anxiety Disorder 7-Item (GAD-7) instrument was available. GAD-7 scores greater than or equal to 10 indicated the presence of moderate to severe PSA. Multivariable logistic regression was used to identify independent sociodemographic and clinical factors associated with PSA.
RESULTS: Records from 289 stroke patients with a GAD-7 instrument were analyzed. PSA was common (21%; GAD-7 ≥ 10). Fifty-seven percent of females had a GAD-7 greater than or equal to 10 compared to 41% of females who had a GAD-7 less than 10 (P = .03). Multivariable analysis found that self-reported nonmarried status (odds ratio, 3.27; 95% confidence interval, 1.44-7.44), excessive fatigue (odds ratio, 4.46; 95% confidence interval, 1.87-10.63), and depression (odds ratio, 1.24; 95% confidence interval, 1.16-1.33) were independently associated with PSA.
CONCLUSIONS: PSA may occur more frequently in those who report non-married, excessive fatigue, or depression. Trials of PSA interventions should consider the potential impact of social support, depression, and comorbid conditions contributing to post-stroke fatigue, including sleep apnea.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; ischemic attack; neuropsychiatry; stroke; transient attack

Mesh:

Year:  2019        PMID: 31859033     DOI: 10.1016/j.jstrokecerebrovasdis.2019.104582

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  The Efficacy of Integrated Rehabilitation for Post-Stroke Anxiety: Study Protocol for a Prospective, Multicenter, Randomized Controlled Trial.

Authors:  Jie Zhou; Lijuan Fan; Hantong Hu; Ke Shen; Liya Wu; Xiaoqi Lin; Hong Gao
Journal:  Int J Gen Med       Date:  2022-09-06

2.  Internet Access and Usage Among Stroke Survivors and Their Informal Caregivers: Cross-sectional Study.

Authors:  Imama Ali Naqvi; Tahani Casameni Montiel; Yazan Bittar; Norma Hunter; Munachi Okpala; Constance Johnson; Mark G Weiner; Sean Savitz; Anjail Sharrief; Jennifer Elizabeth Sanner Beauchamp
Journal:  JMIR Form Res       Date:  2021-03-08

3.  The efficacy and safety of Jin's three-needle therapy vs. placebo acupuncture on anxiety symptoms in patients with post-stroke anxiety: A study protocol for a randomized controlled trial.

Authors:  Meichen Li; Yuting Wang; Keyi Li; Xiaoyan Xu; Lixing Zhuang
Journal:  Front Psychiatry       Date:  2022-09-07       Impact factor: 5.435

4.  Post-stroke Anxiety Analysis via Machine Learning Methods.

Authors:  Jirui Wang; Defeng Zhao; Meiqing Lin; Xinyu Huang; Xiuli Shang
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

5.  High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID-19 Outbreak.

Authors:  Meiling Yao; Hongjie Li; Ying Luo; Ling Li; Jian Yu
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

6.  Overload of anxiety on postural control impairments in chronic stroke survivors: The role of external focus and cognitive task on the automaticity of postural control.

Authors:  Zahra Ghorbanpour; Ghorban Taghizadeh; Seyed Ali Hosseini; Ebrahim Pishyareh; Farhad Tabatabai Ghomsheh; Enayatollah Bakhshi; Hajar Mehdizadeh
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.